Literature DB >> 19416438

Pain syndromes in sickle cell disease: an update.

Pasquale Niscola1, Francesco Sorrentino, Laura Scaramucci, Paolo de Fabritiis, Paolo Cianciulli.   

Abstract

OBJECTIVE: Pain has a critical role in the management of sickle cell disease (SCD). Patients may suffer from several pain syndromes, which may be or not may be associated with other clinical complications, such as anemia, organ failures, and infections.
DESIGN: Data for review were identified by using PubMed to search MEDLINE, limiting the search to abstract/articles in English, Italian, French, and Dutch. The key words pain, sickle cell disease, anemia, hemoglobin, hemoglobinopathy, analgesics, opioids, morphine, acetaminophen, paracetamol, nonsteroidal anti-inflammatory drugs, hematology, and quality of life were variously combined in the title, abstract, and key word search list. The abstract database of most hematological congresses and the bibliographies of most relevant articles were also considered.
RESULTS: There are two major types of SCD pain: acute and chronic. Sometimes, mixed and neuropathic pain can be also observed. Acute pain is mostly related to vaso-occlusion. Chronic pain may be due to some SCD complications, such as leg ulcers and avascular necrosis.
CONCLUSIONS: Pain management in the SCD setting needs multidisciplinary approaches, given the several syndromes and the pathogenic mechanisms that are likely involved. Pain management is not standardized and often difficult, so that many patients with SCD are still poorly treated. Further efforts to develop care plans and treatment protocols as well as management guidelines are required.

Entities:  

Mesh:

Year:  2009        PMID: 19416438     DOI: 10.1111/j.1526-4637.2009.00601.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  19 in total

1.  Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.

Authors:  Gabriela Calhoun; Li Wang; Luis E F Almeida; Nicholas Kenyon; Nina Afsar; Mehdi Nouraie; Julia C Finkel; Zenaide M N Quezado
Journal:  Eur J Pharmacol       Date:  2015-02-25       Impact factor: 4.432

2.  Understanding the Self-Management Practices of Young Adults with Sickle Cell Disease.

Authors:  Nadine Matthie; Coretta Jenerette
Journal:  J Sick Cell Dis Hemoglobinopathies       Date:  2017-05

3.  USING LIVED EXPERIENCES OF ADULTS TO UNDERSTAND CHRONIC PAIN: SICKLE CELL DISEASE, AN EXEMPLAR.

Authors:  Maxine A Adegbola
Journal:  Imanagers J Nurs       Date:  2011

Review 4.  Management of sickle cell disease in the community.

Authors:  Valentine Brousse; Julie Makani; David C Rees
Journal:  BMJ       Date:  2014-03-10

5.  Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612

6.  A biopsychosocial-spiritual model of chronic pain in adults with sickle cell disease.

Authors:  Lou Ella V Taylor; Nancy A Stotts; Janice Humphreys; Marsha J Treadwell; Christine Miaskowski
Journal:  Pain Manag Nurs       Date:  2011-12-14       Impact factor: 1.929

7.  Sickle cell disease in adults: developing an appropriate care plan.

Authors:  Nadine Matthie; Coretta Jenerette
Journal:  Clin J Oncol Nurs       Date:  2015-10       Impact factor: 1.027

8.  Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.

Authors:  Marilyn J Telen; Araba Afenyi-Annan; Melanie E Garrett; Martha R Combs; Eugene P Orringer; Allison E Ashley-Koch
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

9.  Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.

Authors:  Cheedy Jaja; Latanya Bowman; Leigh Wells; Niren Patel; Hongyan Xu; Matt Lyon; Abdullah Kutlar
Journal:  Clin Transl Sci       Date:  2015-02-02       Impact factor: 4.689

10.  CYP2C9 allelic variants and frequencies in a pediatric sickle cell disease cohort: implications for NSAIDs pharmacotherapy.

Authors:  Cheedy Jaja; Niren Patel; Stuart A Scott; Robert Gibson; Abdullah Kutlar
Journal:  Clin Transl Sci       Date:  2014-05-29       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.